Formosa Laboratories Inc
TWSE:4746

Watchlist Manager
Formosa Laboratories Inc Logo
Formosa Laboratories Inc
TWSE:4746
Watchlist
Price: 74.2 TWD 0.82%
Market Cap: 8.9B TWD

Operating Margin
Formosa Laboratories Inc

15.3%
Current
7%
Average
6.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
15.3%
=
Operating Profit
701.6m
/
Revenue
4.6B

Operating Margin Across Competitors

Formosa Laboratories Inc
Glance View

Market Cap
8.9B TWD
Industry
Pharmaceuticals

Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

Intrinsic Value
106.01 TWD
Undervaluation 30%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
15.3%
=
Operating Profit
701.6m
/
Revenue
4.6B
What is the Operating Margin of Formosa Laboratories Inc?

Based on Formosa Laboratories Inc's most recent financial statements, the company has Operating Margin of 15.3%.

Back to Top